Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06213870
Other study ID # TJHH-2023-WM51
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 1, 2022
Est. completion date November 1, 2023

Study information

Verified date January 2024
Source Tianjin Huanhu Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to learn about the role of MRI evaluation based on FVH-DWI mismatch principle in preoperative evaluation of endovascular thrombolectomy. The main questions it aims to answer are: - The consistency between MRI and perfusion examination in determining EVT indications. - The consistency of functional independence rate between patients screening with MRI and perfusion.


Description:

MRI is the preferred imaging mode in many centers,for the diffusion-weighted imaging (DWI) sequences are highly sensitive to acute cerebral ischemia.In addition, MRI does not require intravenous contrast agent, which is simpler and more popular than perfusion.Fluid-attenuated inversion recovery (FLAIR)sequence vascular hyperintensity(FVH) is defined as focal, serpentine, or linear hyperintensity that usually occurs in the Sylvian fissure and is associated with large-vessel occlusion or stenosis.The FVH-DWI mismatch(defined as the FVH extended beyond the boundary of the DWI cortical lesions) had been confirmed has excellent sensitivity and specificity in predicting PWI-DWI mismatch.It is not well established whether MRI based on FVH-DWI mismatch and perfusion evaluation differ in determining EVT indications and outcomes. The main objectives of this study were to (1) determine the proportion of patients eligible for EVT surgery selected by MRI based on FVH-DWI mismatch vs perfusion in a large multicenter registry and (2) identify statistical differences in functional outcomes and safety outcomes between the two evaluation methods. Patients with ischemic stroke with anterior-circulation large-vessel occlusion in the late (6-24 h) time window from real-world, single center retrospective cohort registry were compared.In the MRI group, patients with FVH-DWI mismatch underwent EVT surgery or were otherwise treated with medication.In the perfusion group, surgical indications referring the DEFUSE 3 standards. The primary outcome was 90-day functional independence rate (mRS score ≤2) in all patients included(including EVT patient and medication patients).Safety outcomes included symptomatic intracranial hemorrhage (sICH), and 90-day mortality.


Recruitment information / eligibility

Status Completed
Enrollment 309
Est. completion date November 1, 2023
Est. primary completion date August 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - (1) age = 18 years old; - (2) symptoms consistent with acute ischemic stroke and an onset time of 6-24h; - (3) CT ASPECTS score=6 points;NIHSS=6points; modified Rankin scale (mRS) of 0-2 points prior to stroke; - (4) internal carotid artery (ICA) and/or M1 segment of middle cerebral artery (MCA-M1) and M2 proximal segment occlusion with definite diagnosis. - (5)agree to comply with the protocol follow-up requirements. Exclusion Criteria: - (1)Image unanalyzable. - (2)3 months follow-up was not completed

Study Design


Intervention

Diagnostic Test:
Surgical criteria
In the MRI group, patients with FVH-DWI mismatch underwent EVT surgery or were otherwise treated with medication. In the perfusion group, patients who meet the criteria of DEFUSE3 will receive EVT surgery, otherwise receive medication.

Locations

Country Name City State
China Tianjin Huanhu Hospital Tianjin Tianjin

Sponsors (1)

Lead Sponsor Collaborator
Tianjin Huanhu Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other 90-day mortality Death from any cause within 90 days 90days
Primary 90-day functional independence rate Proportion of patients with mRS0-2 scores at 90 days 90days
Secondary symptomatic intracranial hemorrhage according to the definition proposed by European Cooperative Acute Stroke Study III: intracranial hemorrhage that is associated with deterioration in NIHSS of 4 or more points and the main reason for neurological deterioration 90days
See also
  Status Clinical Trial Phase
Completed NCT04484350 - Blood Pressure Management in Stroke Following Endovascular Treatment Phase 2
Recruiting NCT04121611 - Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior Circulation N/A
Recruiting NCT04517383 - Effects of Post-Operative Sedation for Endovascular Thrombectomy N/A
Enrolling by invitation NCT06361017 - The Prediction of Hemorrhage Transformation by Cerebral Autoregulation in AIS Patient After Endovascular Thrombectomy
Recruiting NCT05708079 - Multidimensional Evaluation of Patients With Acute Ischemic Stroke Undergoing Pharmacological and Endovascular Revascularization Procedures for the Identification of Positive Prognostic Factors
Recruiting NCT06094569 - Medical Imaging Screening for Posterior-circulation Ischemic Stroke
Completed NCT05684172 - Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior Circulation Phase 2/Phase 3
Completed NCT04116112 - Blood Pressure After Endovascular Stroke Therapy-II Phase 2
Completed NCT06290076 - A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy
Recruiting NCT05735301 - MR Imaging Selection for Endovascular Treatment in Acute Ischemic Stroke at 6 to 24 Hours N/A
Recruiting NCT06200753 - Triage of Patients Presenting Beyond 24 Hours With Acute Ischemic Stroke Due to Large Vessel Occlusions (TRACK-LVO Late)
Completed NCT04667637 - Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol Phase 2
Recruiting NCT06146790 - Evaluation of Endovascular Treatment in Acute Intracranial Distal Medium Vessel Occlusion Stroke N/A